var data={"title":"Renal disease in sarcoidosis","body":"<div id=\"topicContent\" class=\"utdArticleSection utdStyle\"><div id=\"topicTitle\">Renal disease in sarcoidosis</div><dl id=\"topicContributors\"><dt><span> </span>Authors:</dt><dd><a href=\"https://www.uptodate.com/contents/renal-disease-in-sarcoidosis/contributors\" class=\"contributor contributor_credentials\">Gianfranco Rizzato, MD</a></dd><dd><a href=\"https://www.uptodate.com/contents/renal-disease-in-sarcoidosis/contributors\" class=\"contributor contributor_credentials\">Gabriel Choukroun, MD, PhD</a></dd><dt><span> </span>Section Editor:</dt><dd><a href=\"https://www.uptodate.com/contents/renal-disease-in-sarcoidosis/contributors\" class=\"contributor contributor_credentials\">Gary C Curhan, MD, ScD</a></dd><dt><span> </span>Deputy Editor:</dt><dd><a href=\"https://www.uptodate.com/contents/renal-disease-in-sarcoidosis/contributors\" class=\"contributor contributor_credentials\">Alice M Sheridan, MD</a></dd></dl><p class=\"disclosureLink\"><a href=\"https://www.uptodate.com/contents/renal-disease-in-sarcoidosis/contributor-disclosure\" class=\"contributor contributor_credentials\">Contributor Disclosures</a></p><div id=\"reviewProcess\"><span>All topics are updated as new evidence becomes available and our <a href=\"https://www.uptodate.com/home/editorial-policy\" target=\"_blank\" class=\"policy policy_editorialpolicy\">peer review process</a> is complete.</span></div><div id=\"literatureReviewDate\"><span class=\"emphasis\">Literature review current through:</span>&#160;Feb 2018.&#160;&#124;&#160;<span class=\"emphasis\">This topic last updated:</span>&#160;Jan 05, 2018.</div><div id=\"topicWhatsNewContainer\"></div><div id=\"topicText\"><p class=\"headingAnchor\" id=\"H215467823\"><span class=\"h1\">INTRODUCTION</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Clinically important renal involvement occasionally occurs in sarcoidosis. Renal manifestations include abnormal calcium metabolism, nephrolithiasis and nephrocalcinosis, and acute interstitial nephritis with or without granuloma formation. The classic renal lesion is noncaseating granulomatous interstitial nephritis. However, this lesion rarely causes clinically significant renal disease. Hypercalciuria and hypercalcemia are most often responsible for clinically significant renal disease. Glomerular disease, obstructive uropathy, and end-stage renal disease (ESRD) may also occur but are uncommon [<a href=\"https://www.uptodate.com/contents/renal-disease-in-sarcoidosis/abstract/1,2\" class=\"abstract_t\">1,2</a>].</p><p>The renal manifestations of sarcoidosis will be reviewed here. General issues related to sarcoidosis and its pathogenesis are discussed separately. (See <a href=\"topic.htm?path=clinical-manifestations-and-diagnosis-of-pulmonary-sarcoidosis\" class=\"medical medical_review\">&quot;Clinical manifestations and diagnosis of pulmonary sarcoidosis&quot;</a> and <a href=\"topic.htm?path=pathology-and-pathogenesis-of-sarcoidosis\" class=\"medical medical_review\">&quot;Pathology and pathogenesis of sarcoidosis&quot;</a>.)</p><p class=\"headingAnchor\" id=\"H2\"><span class=\"h1\">EPIDEMIOLOGY</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>The incidence and prevalence of renal involvement in sarcoidosis remain uncertain [<a href=\"https://www.uptodate.com/contents/renal-disease-in-sarcoidosis/abstract/3\" class=\"abstract_t\">3</a>].</p><p>The reported prevalence ranges widely due to the enormous variation in study design and enrolled patient populations and due to the heterogeneity and often asymptomatic nature of renal disease.</p><p>Several small series have suggested that renal involvement (as defined by either histologic changes in the kidney or a decline in renal function in the absence of a biopsy) occurs in approximately 35 to 50 percent of patients [<a href=\"https://www.uptodate.com/contents/renal-disease-in-sarcoidosis/abstract/4-7\" class=\"abstract_t\">4-7</a>], even if, in most cases, the disease may be silent and undetected for many years or forever. In one study, among 46 patients with acute or chronic sarcoidosis, 15 patients had renal abnormalities [<a href=\"https://www.uptodate.com/contents/renal-disease-in-sarcoidosis/abstract/7\" class=\"abstract_t\">7</a>].</p><p>Several studies have examined the relative prevalence of the various renal lesions associated with sarcoidosis:</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Overall, nephrocalcinosis is estimated to occur in 5 percent of patients with sarcoidosis [<a href=\"https://www.uptodate.com/contents/renal-disease-in-sarcoidosis/abstract/8\" class=\"abstract_t\">8</a>]. Nephrocalcinosis may be the most common cause of chronic kidney disease (CKD) [<a href=\"https://www.uptodate.com/contents/renal-disease-in-sarcoidosis/abstract/1,7,9\" class=\"abstract_t\">1,7,9</a>]. (See <a href=\"topic.htm?path=nephrocalcinosis\" class=\"medical medical_review\">&quot;Nephrocalcinosis&quot;</a>.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Nephrolithiasis occurs in approximately 1 to 14 percent of patients with sarcoidosis [<a href=\"https://www.uptodate.com/contents/renal-disease-in-sarcoidosis/abstract/1,5,10,11\" class=\"abstract_t\">1,5,10,11</a>].</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Interstitial nephritis with granuloma formation occurs in approximately 20 percent of patients [<a href=\"https://www.uptodate.com/contents/renal-disease-in-sarcoidosis/abstract/10\" class=\"abstract_t\">10</a>]. However, renal insufficiency is not always present (<a href=\"image.htm?imageKey=NEPH%2F67591\" class=\"graphic graphic_picture graphicRef67591 \">picture 1</a>) [<a href=\"https://www.uptodate.com/contents/renal-disease-in-sarcoidosis/abstract/2,12-15\" class=\"abstract_t\">2,12-15</a>]. As an example, a survey of all renal biopsies over a six-year period at three general hospitals found clinically significant sarcoid granulomatous interstitial nephritis in only four cases [<a href=\"https://www.uptodate.com/contents/renal-disease-in-sarcoidosis/abstract/16-18\" class=\"abstract_t\">16-18</a>]. Patients who have interstitial nephritis may also have nephrolithiasis or nephrocalcinosis [<a href=\"https://www.uptodate.com/contents/renal-disease-in-sarcoidosis/abstract/19\" class=\"abstract_t\">19</a>]. In one study that included a cohort of 27 patients with renal sarcoidosis (four of them with isolated renal; all the others with systemic sarcoidosis), the most commonly observed histologic lesion was nongranulomatous tubulointerstitial nephritis (44 percent), followed by granulomatous tubulointerstitial nephritis (30 percent), immunoglobulin A (IgA) glomerulonephritis (26 percent), and nephrocalcinosis (11 percent) [<a href=\"https://www.uptodate.com/contents/renal-disease-in-sarcoidosis/abstract/20\" class=\"abstract_t\">20</a>].</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Glomerular involvement is rare. A variety of different lesions have been described in isolated cases, including membranous nephropathy, IgA nephropathy, minimal change disease, a proliferative or crescentic glomerulonephritis, and focal segmental glomerulosclerosis [<a href=\"https://www.uptodate.com/contents/renal-disease-in-sarcoidosis/abstract/2,21-24\" class=\"abstract_t\">2,21-24</a>].</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Urinary tract obstruction is very rare among patients with sarcoidosis.</p><p/><p class=\"headingAnchor\" id=\"H778374900\"><span class=\"h1\">PROGNOSIS</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>End-stage renal disease (ESRD) requiring some form of renal replacement therapy is uncommon. When it occurs, ESRD is most often due to hypercalcemic nephropathy rather than granulomatous nephritis or a glomerulonephropathy, although nephrocalcinosis is less common overall than interstitial nephritis. In the largest observational study, among 46 patients with sarcoidosis-related interstitial nephritis, only two progressed to ESRD (at 15 and 2 years after presentation) [<a href=\"https://www.uptodate.com/contents/renal-disease-in-sarcoidosis/abstract/19\" class=\"abstract_t\">19</a>]. However, 66 percent of patients had an estimated glomerular filtration rate (eGFR) &lt;60 <span class=\"nowrap\">mL/min/1</span>.73 m<sup>2</sup> at a median follow-up of 24 months.</p><p class=\"headingAnchor\" id=\"H778373296\"><span class=\"h1\">NEPHROLITHIASIS AND NEPHROCALCINOSIS</span></p><p class=\"headingAnchor\" id=\"H197103143\"><span class=\"h2\">Pathogenesis</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Nephrocalcinosis and nephrolithiasis are caused by hypercalcemia <span class=\"nowrap\">and/or</span> hypercalciuria.</p><p>Hyperabsorption of dietary calcium occurs in up to 50 percent of cases of sarcoidosis [<a href=\"https://www.uptodate.com/contents/renal-disease-in-sarcoidosis/abstract/1\" class=\"abstract_t\">1</a>]. The excess calcium is excreted in the urine, leading to hypercalciuria in approximately 40 percent and, in 2 to 20 percent of cases, to hypercalcemia [<a href=\"https://www.uptodate.com/contents/renal-disease-in-sarcoidosis/abstract/1,2,16-18\" class=\"abstract_t\">1,2,16-18</a>].</p><p>This abnormality in calcium metabolism is not limited to sarcoidosis, as it occurs in many other chronic granulomatous diseases. The defect in these disorders is increased production of calcitriol (1,25 dihydroxyvitamin D, the most active metabolite of vitamin D) by activated mononuclear cells (particularly macrophages) in granulomas, the lung, and lymph nodes. Increased calcitriol production appears to be due both to markedly enhanced activation and production of 1-alpha-hydroxylase, the enzyme that converts 25-hydroxyvitamin D to calcitriol, and the absence of feedback inhibition, which normally limits enzyme expression [<a href=\"https://www.uptodate.com/contents/renal-disease-in-sarcoidosis/abstract/25\" class=\"abstract_t\">25</a>]. (See <a href=\"topic.htm?path=hypercalcemia-in-granulomatous-diseases\" class=\"medical medical_review\">&quot;Hypercalcemia in granulomatous diseases&quot;</a>.)</p><p class=\"headingAnchor\" id=\"H778373487\"><span class=\"h2\">Clinical manifestations</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Nephrolithiasis may be the presenting feature of sarcoidosis [<a href=\"https://www.uptodate.com/contents/renal-disease-in-sarcoidosis/abstract/1,5,10,11\" class=\"abstract_t\">1,5,10,11</a>]. Signs and symptoms of nephrolithiasis are discussed elsewhere. (See <a href=\"topic.htm?path=diagnosis-and-acute-management-of-suspected-nephrolithiasis-in-adults#H4\" class=\"medical medical_review\">&quot;Diagnosis and acute management of suspected nephrolithiasis in adults&quot;, section on 'Clinical manifestations'</a>.)</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>In a retrospective study of 618 patients with sarcoidosis, renal calculi were the first manifestations in 14 (2.2 percent) [<a href=\"https://www.uptodate.com/contents/renal-disease-in-sarcoidosis/abstract/26\" class=\"abstract_t\">26</a>]. In another nine patients who presented with pulmonary involvement, persistent hematuria or pyuria led to the discovery of asymptomatic calculi via ultrasonography or intravenous (IV) pyelography. Thus, 23 patients (3.7 percent) had renal calculi at presentation.</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>In a prospective study, nephrolithiasis was the presenting feature of the disease in 4 percent of 204 consecutive patients with sarcoidosis [<a href=\"https://www.uptodate.com/contents/renal-disease-in-sarcoidosis/abstract/27\" class=\"abstract_t\">27</a>].</p><p/><p>The stones are usually of calcium oxalate, sometimes mixed with calcium phosphate.</p><p>Patients with nephrocalcinosis may present only with an elevated creatinine and benign urinalysis. Such patients will generally be found to have hypercalciuria with or without hypercalcemia. (See <a href=\"topic.htm?path=nephrocalcinosis#H19\" class=\"medical medical_review\">&quot;Nephrocalcinosis&quot;, section on 'Clinical presentation'</a>.)</p><p>Patients with nephrocalcinosis may have polyuria, which is caused by hypercalcemia and possibly hypercalciuria, resulting in reduced responsiveness to antidiuretic hormone [<a href=\"https://www.uptodate.com/contents/renal-disease-in-sarcoidosis/abstract/28\" class=\"abstract_t\">28</a>]. Polyuria in sarcoidosis may reflect central diabetes insipidus (ie, lack of antidiuretic hormone) or primary polydipsia due to granulomatous infiltration of the hypothalamus [<a href=\"https://www.uptodate.com/contents/renal-disease-in-sarcoidosis/abstract/29\" class=\"abstract_t\">29</a>] (see <a href=\"topic.htm?path=clinical-manifestations-and-causes-of-nephrogenic-diabetes-insipidus\" class=\"medical medical_review\">&quot;Clinical manifestations and causes of nephrogenic diabetes insipidus&quot;</a> and <a href=\"topic.htm?path=diagnosis-of-polyuria-and-diabetes-insipidus\" class=\"medical medical_review\">&quot;Diagnosis of polyuria and diabetes insipidus&quot;</a>). Hypercalcemia may also cause a decreased glomerular filtration rate (GFR) through preglomerular arteriolar vasoconstriction [<a href=\"https://www.uptodate.com/contents/renal-disease-in-sarcoidosis/abstract/30\" class=\"abstract_t\">30</a>].</p><p class=\"headingAnchor\" id=\"H778374472\"><span class=\"h2\">Diagnosis</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>The evaluation of nephrolithiasis and nephrocalcinosis is discussed elsewhere. (See <a href=\"topic.htm?path=diagnosis-and-acute-management-of-suspected-nephrolithiasis-in-adults\" class=\"medical medical_review\">&quot;Diagnosis and acute management of suspected nephrolithiasis in adults&quot;</a> and <a href=\"topic.htm?path=nephrocalcinosis\" class=\"medical medical_review\">&quot;Nephrocalcinosis&quot;</a>.)</p><p class=\"headingAnchor\" id=\"H778374390\"><span class=\"h2\">Differential diagnosis</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>The differential diagnosis of sarcoidosis-related nephrocalcinosis and nephrolithiasis includes conditions that cause hypercalcemia and hypercalciuria (primary hyperparathyroidism, vitamin D therapy, milk-alkali syndrome, other granulomatous diseases, and congenital hypothyroidism) and conditions that cause hypercalciuria in the absence of hypercalcemia (distal renal tubular acidosis, medullary sponge kidney, neonatal nephrocalcinosis and loop diuretics, inherited tubulopathies, and chronic hypokalemia). (See <a href=\"topic.htm?path=nephrocalcinosis\" class=\"medical medical_review\">&quot;Nephrocalcinosis&quot;</a>.)</p><p class=\"headingAnchor\" id=\"H778375028\"><span class=\"h2\">Treatment</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Glucocorticoids (which decrease inflammatory activity and therefore calcitriol synthesis), <a href=\"topic.htm?path=chloroquine-drug-information\" class=\"drug drug_general\">chloroquine</a>, <a href=\"topic.htm?path=hydroxychloroquine-drug-information\" class=\"drug drug_general\">hydroxychloroquine</a>, and <a href=\"topic.htm?path=ketoconazole-drug-information\" class=\"drug drug_general\">ketoconazole</a> can improve calcium metabolism in patients with sarcoidosis. A more complete discussion of the pathogenesis and treatment of this problem is presented separately. (See <a href=\"topic.htm?path=hypercalcemia-in-granulomatous-diseases\" class=\"medical medical_review\">&quot;Hypercalcemia in granulomatous diseases&quot;</a>.)</p><p class=\"headingAnchor\" id=\"H778373310\"><span class=\"h1\">INTERSTITIAL NEPHRITIS</span></p><p class=\"headingAnchor\" id=\"H778373331\"><span class=\"h2\">Pathogenesis</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>The pathogenesis of granuloma formation in sarcoidosis is extensively discussed elsewhere. (See <a href=\"topic.htm?path=pathology-and-pathogenesis-of-sarcoidosis\" class=\"medical medical_review\">&quot;Pathology and pathogenesis of sarcoidosis&quot;</a>.)</p><p class=\"headingAnchor\" id=\"H778373722\"><span class=\"h2\">Clinical manifestations</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Sarcoid-related interstitial nephritis is usually identified on the initial presentation of sarcoidosis and rarely develops among patients who have a longstanding diagnosis of sarcoidosis [<a href=\"https://www.uptodate.com/contents/renal-disease-in-sarcoidosis/abstract/19\" class=\"abstract_t\">19</a>]. This was demonstrated in a retrospective review of 47 patients with biopsy-proven interstitial nephritis (37 with noncaseating granulomas and 10 with interstitial nephritis without granulomas) [<a href=\"https://www.uptodate.com/contents/renal-disease-in-sarcoidosis/abstract/19\" class=\"abstract_t\">19</a>]. Among 38 patients (81 percent), the renal lesion was diagnosed concurrently with at least one other site of sarcoidosis involvement.</p><p>Most patients with interstitial nephritis present with an elevated creatinine that is detected on routine screening or as part of their initial evaluation for sarcoidosis. In a study cited above, among 47 patients with sarcoidosis interstitial nephritis, 46 presented with an elevated creatinine at diagnosis [<a href=\"https://www.uptodate.com/contents/renal-disease-in-sarcoidosis/abstract/19\" class=\"abstract_t\">19</a>].</p><p>Twenty-nine patients (62.5 percent) were already in stage 4 or 5 of chronic kidney disease (CKD) at presentation [<a href=\"https://www.uptodate.com/contents/renal-disease-in-sarcoidosis/abstract/19\" class=\"abstract_t\">19</a>].</p><p>Most patients with renal involvement have clear evidence of diffuse active sarcoidosis [<a href=\"https://www.uptodate.com/contents/renal-disease-in-sarcoidosis/abstract/12,19,31-33\" class=\"abstract_t\">12,19,31-33</a>]. As an example, among 47 patients, 42 (90 percent) had thoracic involvement identified on chest radiograph [<a href=\"https://www.uptodate.com/contents/renal-disease-in-sarcoidosis/abstract/19\" class=\"abstract_t\">19</a>]. Systemic symptoms, including fatigue, weight loss, and fever, were present in 20 patients (42 percent).</p><p>The urinary manifestations of interstitial nephritis are relatively nonspecific. The urinalysis is either normal or shows only sterile pyuria or mild proteinuria. In a review of 52 cases of sarcoidosis interstitial nephritis, sterile pyuria, hematuria, glycosuria, and hypercalciuria were identified in 33, 21, 12, and 8 percent, respectively [<a href=\"https://www.uptodate.com/contents/renal-disease-in-sarcoidosis/abstract/8\" class=\"abstract_t\">8</a>]. Significant proteinuria is uncommon. In a prospective review of 191 sarcoid patients, proteinuria, defined as urine <span class=\"nowrap\">protein/creatinine</span> ratio equal to or exceeding 0.3 <span class=\"nowrap\">mg/mg,</span> was found in 7 percent of patients [<a href=\"https://www.uptodate.com/contents/renal-disease-in-sarcoidosis/abstract/34\" class=\"abstract_t\">34</a>]. More than half of these patients had a known risk factor for proteinuria (diabetes, hepatitis B or C infection, human immunodeficiency virus [HIV], systemic lupus erythematosus, or congestive heart failure).</p><p class=\"headingAnchor\" id=\"H778373995\"><span class=\"h2\">Diagnosis</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>The diagnosis of sarcoidosis interstitial nephritis should be suspected among patients who present with an elevated serum creatinine and bland urine sediment and have either a known diagnosis or characteristic presentation of extrarenal sarcoidosis. (See <a href=\"topic.htm?path=clinical-manifestations-and-diagnosis-of-pulmonary-sarcoidosis\" class=\"medical medical_review\">&quot;Clinical manifestations and diagnosis of pulmonary sarcoidosis&quot;</a>.)</p><p>The diagnosis of sarcoidosis interstitial nephritis is strongly suggested by renal biopsy. Renal biopsy reveals normal glomeruli; interstitial infiltration, mostly with mononuclear cells; noncaseating granulomas in the interstitium; tubular injury; and, with more chronic disease, interstitial fibrosis.</p><p>However, these findings are suggestive, but not diagnostic, of sarcoidosis. In one retrospective review of 40 cases of renal granulomatoses, 20 were due to sarcoidosis, and the remainder resulted from drug reactions (seven cases), tuberculosis (three), granulomatosis with polyangiitis (Wegener's) (two), leprosy (one), mycobacterium avium (one), and Crohn disease (one) [<a href=\"https://www.uptodate.com/contents/renal-disease-in-sarcoidosis/abstract/35\" class=\"abstract_t\">35</a>]. No etiology could be identified in five cases in this study.</p><p>There is no single diagnostic test for sarcoidosis. Thus, in the setting of granulomatous interstitial nephritis, one must rely upon the exclusion of other etiologies of interstitial nephritis and upon the demonstration of extrarenal manifestations of sarcoidosis to be confident of the diagnosis. (See <a href=\"topic.htm?path=clinical-manifestations-and-diagnosis-of-acute-interstitial-nephritis#H853752222\" class=\"medical medical_review\">&quot;Clinical manifestations and diagnosis of acute interstitial nephritis&quot;, section on 'Histology'</a> and <a href=\"topic.htm?path=clinical-manifestations-and-diagnosis-of-acute-interstitial-nephritis#H451377368\" class=\"medical medical_review\">&quot;Clinical manifestations and diagnosis of acute interstitial nephritis&quot;, section on 'Establishing the cause'</a> and <a href=\"topic.htm?path=clinical-manifestations-and-diagnosis-of-pulmonary-sarcoidosis#H37\" class=\"medical medical_review\">&quot;Clinical manifestations and diagnosis of pulmonary sarcoidosis&quot;, section on 'Diagnostic approach'</a>.)</p><p>Occasionally, patients with renal sarcoidosis have no extrarenal manifestations of sarcoidosis upon presentation. Thus, all patients who have granulomatous interstitial nephritis detected on biopsy should have a chest radiograph and pulmonary function tests and, if these are nondiagnostic, a high-resolution chest computed tomography (CT) scan to evaluate for pulmonary sarcoidosis. (See <a href=\"topic.htm?path=clinical-manifestations-and-diagnosis-of-pulmonary-sarcoidosis#H37\" class=\"medical medical_review\">&quot;Clinical manifestations and diagnosis of pulmonary sarcoidosis&quot;, section on 'Diagnostic approach'</a>.)</p><p>Measurement of serum calcium, 24-hour urinary calcium concentration, and a serum angiotensin-converting enzyme (ACE) concentration may also provide support for the diagnosis of sarcoidosis.</p><p class=\"headingAnchor\" id=\"H778374278\"><span class=\"h2\">Differential diagnosis</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Among patients with interstitial nephritis, other conditions that must be considered include drug-induced interstitial nephritis, tuberculosis, other mycobacterium infections, granulomatosis with polyangiitis (Wegener's), brucellosis, histoplasmosis, tubulointerstitial nephritis with uveitis (TINU) syndrome, and, rarely, Crohn disease [<a href=\"https://www.uptodate.com/contents/renal-disease-in-sarcoidosis/abstract/35-37\" class=\"abstract_t\">35-37</a>]. (See <a href=\"topic.htm?path=clinical-manifestations-and-diagnosis-of-acute-interstitial-nephritis\" class=\"medical medical_review\">&quot;Clinical manifestations and diagnosis of acute interstitial nephritis&quot;</a>.)</p><p class=\"headingAnchor\" id=\"H778374594\"><span class=\"h2\">Treatment</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>We treat all patients who have a reduced estimated glomerular filtration rate (eGFR) related to biopsy-demonstrated sarcoidosis interstitial nephritis with glucocorticoids. Glucocorticoids (up to 1 <span class=\"nowrap\">mg/kg/day)</span> have been shown to be effective among such patients, although the recovery is often incomplete due to longstanding disease with irreversible renal damage [<a href=\"https://www.uptodate.com/contents/renal-disease-in-sarcoidosis/abstract/12,15,19,31\" class=\"abstract_t\">12,15,19,31</a>]. The response to glucocorticoids was best noted in a study of 47 patients with renal sarcoidosis [<a href=\"https://www.uptodate.com/contents/renal-disease-in-sarcoidosis/abstract/19\" class=\"abstract_t\">19</a>]. All patients received <a href=\"topic.htm?path=prednisone-drug-information\" class=\"drug drug_general\">prednisone</a>, while 10 also received intravenous (IV) pulse <a href=\"topic.htm?path=methylprednisolone-drug-information\" class=\"drug drug_general\">methylprednisolone</a>. At a median follow-up of 24 months, the following was noted:</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>A complete and partial response occurred in 30 and 5 patients, respectively.</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>No response was reported in those with &gt;50 percent fibrosis by histologic examination.</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>The presence of hypercalcemia on presentation correlated with a complete response to glucocorticoid therapy at one year (odds ratio [OR] 16, 95% CI 1.8-137).</p><p/><p>The interpretation of this study is limited by the fact that the reported results were not adjusted for other factors that may have affected response to therapy.</p><p>There are limited data to guide glucocorticoid therapy. Based on the study cited above, we suggest oral <a href=\"topic.htm?path=prednisone-drug-information\" class=\"drug drug_general\">prednisone</a> 1 <span class=\"nowrap\">mg/kg/day</span> for 6 to 12 weeks, followed by a slow taper thereafter to a maintenance dose of 10 to 20 mg for an additional six to nine months [<a href=\"https://www.uptodate.com/contents/renal-disease-in-sarcoidosis/abstract/19\" class=\"abstract_t\">19</a>]. Relapses can occur in responders if glucocorticoids are tapered too rapidly, and some patients need low doses indefinitely. In one series of five patients, the only individual who relapsed received &lt;20 <span class=\"nowrap\">mg/day</span> of <a href=\"topic.htm?path=prednisolone-drug-information\" class=\"drug drug_general\">prednisolone</a> for the first three months of therapy [<a href=\"https://www.uptodate.com/contents/renal-disease-in-sarcoidosis/abstract/14\" class=\"abstract_t\">14</a>].</p><p>In patients with sarcoidosis interstitial nephritis who cannot tolerate or who do not respond to glucocorticoids, alternative therapies that are effective in pulmonary sarcoidosis may be attempted, such as <a href=\"topic.htm?path=methotrexate-drug-information\" class=\"drug drug_general\">methotrexate</a>, <a href=\"topic.htm?path=chloroquine-drug-information\" class=\"drug drug_general\">chloroquine</a>, <a href=\"topic.htm?path=azathioprine-drug-information\" class=\"drug drug_general\">azathioprine</a>, a combination of these drugs, or, as a last resort, tumor necrosis factor antagonists or their biosimilars [<a href=\"https://www.uptodate.com/contents/renal-disease-in-sarcoidosis/abstract/38,39\" class=\"abstract_t\">38,39</a>]. (See <a href=\"topic.htm?path=treatment-of-pulmonary-sarcoidosis-disease-refractory-to-glucocorticoid-therapy\" class=\"medical medical_review\">&quot;Treatment of pulmonary sarcoidosis: Disease refractory to glucocorticoid therapy&quot;</a>.)</p><p class=\"headingAnchor\" id=\"H778373317\"><span class=\"h1\">GLOMERULONEPHRITIS</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Patients with sarcoidosis occasionally present with glomerulonephritis, although the mechanism of glomerular injury is not known, nor is the relationship to sarcoidosis proven [<a href=\"https://www.uptodate.com/contents/renal-disease-in-sarcoidosis/abstract/23,40\" class=\"abstract_t\">23,40</a>]. As an example, as noted above, in one study that included 27 patients with biopsy-proven sarcoidosis, 26 percent had immunoglobulin A (IgA) nephropathy [<a href=\"https://www.uptodate.com/contents/renal-disease-in-sarcoidosis/abstract/20\" class=\"abstract_t\">20</a>]. Another report described a patient with sarcoidosis and crescentic glomerulonephritis with interstitial granuloma formation in association with a positive antineutrophil cytoplasmic antibody (ANCA) test, thereby confounding a possible relationship between the glomerular disease and sarcoidosis [<a href=\"https://www.uptodate.com/contents/renal-disease-in-sarcoidosis/abstract/40\" class=\"abstract_t\">40</a>]. Patients with glomerulonephritis present with significant proteinuria or red cell casts, differentiating them from those with interstitial nephritis.</p><p>As in other forms of sarcoid nephropathy, the administration of steroids appears to improve renal function [<a href=\"https://www.uptodate.com/contents/renal-disease-in-sarcoidosis/abstract/20,23,40\" class=\"abstract_t\">20,23,40</a>].</p><p class=\"headingAnchor\" id=\"H778373324\"><span class=\"h1\">URETERAL OBSTRUCTION AND OTHER RENAL MANIFESTATIONS</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Ureteral obstruction may result from retroperitoneal lymph node involvement, retroperitoneal fibrosis, renal stones, and direct ureteral involvement by sarcoid [<a href=\"https://www.uptodate.com/contents/renal-disease-in-sarcoidosis/abstract/41-43\" class=\"abstract_t\">41-43</a>] (see <a href=\"topic.htm?path=clinical-manifestations-and-diagnosis-of-retroperitoneal-fibrosis\" class=\"medical medical_review\">&quot;Clinical manifestations and diagnosis of retroperitoneal fibrosis&quot;</a>). Obstructive uropathy due to retroperitoneal involvement may be responsive to glucocorticoids, but invasive urologic decompression or hemodialysis may be required prior to a clinically significant response [<a href=\"https://www.uptodate.com/contents/renal-disease-in-sarcoidosis/abstract/2,41\" class=\"abstract_t\">2,41</a>]. (See <a href=\"topic.htm?path=treatment-of-retroperitoneal-fibrosis\" class=\"medical medical_review\">&quot;Treatment of retroperitoneal fibrosis&quot;</a>.)</p><p>Retroperitoneal fibrosis can also involve the renal artery, which may be affected by sarcoid angiitis. When present, vasculitis of the renal artery is commonly associated with hypertension [<a href=\"https://www.uptodate.com/contents/renal-disease-in-sarcoidosis/abstract/44\" class=\"abstract_t\">44</a>].</p><p class=\"headingAnchor\" id=\"H12\"><span class=\"h1\">RENAL TRANSPLANTATION</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>The outcome of renal transplantation is not well known. The best data are from a retrospective review of 18 patients from eight French renal transplantation departments [<a href=\"https://www.uptodate.com/contents/renal-disease-in-sarcoidosis/abstract/45\" class=\"abstract_t\">45</a>]. In 10 patients, renal failure was due to granulomatous interstitial nephritis; in eight other patients, no renal biopsy was done. At the end of a median follow-up of four years, patient and death-censored graft survival was 94 percent. The mean glomerular filtration rate (GFR) was 60 <span class=\"nowrap\">mL/min/1</span>.73 m<sup>2</sup>.</p><p>Recurrence of renal sarcoidosis has been described [<a href=\"https://www.uptodate.com/contents/renal-disease-in-sarcoidosis/abstract/45,46\" class=\"abstract_t\">45,46</a>]. In one report, sarcoidosis recurred in five patients (27 percent), including two who had extrarenal involvement and three who had renal involvement [<a href=\"https://www.uptodate.com/contents/renal-disease-in-sarcoidosis/abstract/45\" class=\"abstract_t\">45</a>]. The patients who had renal recurrence had a lower median estimated GFR (eGFR; 31 <span class=\"nowrap\">mL/min/1</span>.73 m<sup>2</sup>) compared with the entire cohort. Recurrence was observed a median of 13 months after transplantation. The relatively high rate of recurrence in patients with sarcoidosis-related primary renal disease suggests that specific clinical and histologic monitoring may be warranted during the early posttransplant period.</p><p class=\"headingAnchor\" id=\"H3406089238\"><span class=\"h1\">SOCIETY GUIDELINE LINKS</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Links to society and government-sponsored guidelines from selected countries and regions around the world are provided separately. (See <a href=\"topic.htm?path=society-guideline-links-chronic-kidney-disease-in-adults\" class=\"medical medical_society_guidelines\">&quot;Society guideline links: Chronic kidney disease in adults&quot;</a>.)</p><p class=\"headingAnchor\" id=\"H13\"><span class=\"h1\">SUMMARY AND RECOMMENDATIONS</span></p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Renal involvement, defined by either histologic changes in the kidney or a decline in renal function, occurs in approximately 35 to 50 percent of patients with sarcoidosis, though is commonly undetected. Primary renal manifestations are nephrolithiasis and nephrocalcinosis and acute interstitial nephritis with or without granuloma formation. The classic renal lesion is noncaseating granulomatous interstitial nephritis, but this lesion rarely causes clinically significant renal disease. Hypercalciuria and hypercalcemia are most often responsible for clinically significant renal disease. Glomerular disease, obstructive uropathy, and end-stage renal disease (ESRD) may also occur but are uncommon. (See <a href=\"#H215467823\" class=\"local\">'Introduction'</a> above and <a href=\"#H2\" class=\"local\">'Epidemiology'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Nephrocalcinosis and nephrolithiasis are caused by hypercalcemia <span class=\"nowrap\">and/or</span> hypercalciuria, resulting from hyperabsorption of ingested calcium due to increased production of calcitriol by activated mononuclear cells. The stones are usually composed of calcium oxalate, sometimes mixed with calcium phosphate. Patients may have polyuria and a decreased glomerular filtration rate (GFR) due to hypercalcemia-induced preglomerular arteriole vasoconstriction. Glucocorticoids (which decrease inflammatory activity and therefore calcitriol synthesis), <a href=\"topic.htm?path=chloroquine-drug-information\" class=\"drug drug_general\">chloroquine</a>, <a href=\"topic.htm?path=hydroxychloroquine-drug-information\" class=\"drug drug_general\">hydroxychloroquine</a>, and <a href=\"topic.htm?path=ketoconazole-drug-information\" class=\"drug drug_general\">ketoconazole</a> can improve calcium metabolism in patients with sarcoidosis. (See <a href=\"#H778373296\" class=\"local\">'Nephrolithiasis and nephrocalcinosis'</a> above and <a href=\"topic.htm?path=diagnosis-and-acute-management-of-suspected-nephrolithiasis-in-adults\" class=\"medical medical_review\">&quot;Diagnosis and acute management of suspected nephrolithiasis in adults&quot;</a> and <a href=\"topic.htm?path=nephrocalcinosis\" class=\"medical medical_review\">&quot;Nephrocalcinosis&quot;</a> and <a href=\"topic.htm?path=hypercalcemia-in-granulomatous-diseases\" class=\"medical medical_review\">&quot;Hypercalcemia in granulomatous diseases&quot;</a>.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Patients with sarcoidosis interstitial nephritis present with an elevated serum creatinine that is detected on routine screening or as part of their initial evaluation for sarcoidosis. Most patients have clear evidence of diffuse active sarcoidosis elsewhere. The urinalysis is usually normal or shows sterile pyuria or mild proteinuria. (See <a href=\"#H778373331\" class=\"local\">'Pathogenesis'</a> above and <a href=\"#H778373722\" class=\"local\">'Clinical manifestations'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>There is no single diagnostic test for sarcoidosis. The diagnosis of sarcoidosis interstitial nephritis is suggested by renal biopsy, which shows an interstitial mononuclear infiltrate, noncaseating granulomas, tubular injury, and, with more chronic disease, interstitial fibrosis. These findings are suggestive, but not diagnostic, of sarcoidosis. In the setting of interstitial nephritis, one must rely upon the exclusion of other etiologies and upon the demonstration of extrarenal manifestations of sarcoidosis to be confident of the diagnosis. (See <a href=\"topic.htm?path=clinical-manifestations-and-diagnosis-of-acute-interstitial-nephritis#H853752222\" class=\"medical medical_review\">&quot;Clinical manifestations and diagnosis of acute interstitial nephritis&quot;, section on 'Histology'</a> and <a href=\"topic.htm?path=clinical-manifestations-and-diagnosis-of-acute-interstitial-nephritis#H451377368\" class=\"medical medical_review\">&quot;Clinical manifestations and diagnosis of acute interstitial nephritis&quot;, section on 'Establishing the cause'</a> and <a href=\"topic.htm?path=clinical-manifestations-and-diagnosis-of-pulmonary-sarcoidosis#H37\" class=\"medical medical_review\">&quot;Clinical manifestations and diagnosis of pulmonary sarcoidosis&quot;, section on 'Diagnostic approach'</a>.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Occasionally, patients with renal sarcoidosis have no extrarenal manifestations of sarcoidosis upon presentation. Thus, all patients who have granulomatous interstitial nephritis detected on biopsy should have a chest radiograph, pulmonary function tests, and, if these are nondiagnostic, a high-resolution chest computed tomography (CT) scan to evaluate for pulmonary sarcoidosis. (See <a href=\"topic.htm?path=clinical-manifestations-and-diagnosis-of-pulmonary-sarcoidosis#H37\" class=\"medical medical_review\">&quot;Clinical manifestations and diagnosis of pulmonary sarcoidosis&quot;, section on 'Diagnostic approach'</a>.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Glucocorticoids have been shown to be an effective treatment for patients with interstitial nephritis related to sarcoidosis, although the recovery may be incomplete due to longstanding disease with irreversible renal damage. For all patients who have a reduced estimated GFR (eGFR) related to biopsy-demonstrated sarcoidosis interstitial nephritis, we suggest a trial of oral <a href=\"topic.htm?path=prednisone-drug-information\" class=\"drug drug_general\">prednisone</a> (<a href=\"grade.htm?i=6\" class=\"grade\">Grade 2C</a>). The optimal dose is not known. A suggested regimen is prednisone 1 <span class=\"nowrap\">mg/kg/day</span> for 6 to 12 weeks, with a slow taper thereafter to a maintenance dose of 10 to 20 mg for an additional six to nine months. (See <a href=\"#H778374594\" class=\"local\">'Treatment'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Patients occasionally present with glomerulonephritis, although the relationship to sarcoidosis has not been proven. As in other forms of sarcoid nephropathy, the administration of steroids appears to improve renal function.</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Ureteral obstruction may result from retroperitoneal lymph node involvement, retroperitoneal fibrosis, renal stones, and direct ureteral involvement by sarcoid. Obstructive uropathy due to retroperitoneal involvement may be responsive to glucocorticoids, but invasive urologic decompression or hemodialysis may be required prior to a clinically significant response.</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>ESRD requiring some form of renal replacement therapy is uncommon, although many patients may have a reduced eGFR. (See <a href=\"#H778374900\" class=\"local\">'Prognosis'</a> above.)</p><p/></div><div id=\"topicAgreement\">Use of UpToDate is subject to the <a href=\"https://www.uptodate.com/legal/license\" class=\"licenseLink\" id=\"sla_in_page\">Subscription and License Agreement</a>.</div><div id=\"references\" class=\"headingAnchor\"><h1>REFERENCES</h1><ol id=\"reference\"><li><a href=\"https://www.uptodate.com/contents/renal-disease-in-sarcoidosis/abstract/1\" class=\"nounderline abstract_t\">Muther RS, McCarron DA, Bennett WM. Renal manifestations of sarcoidosis. Arch Intern Med 1981; 141:643.</a></li><li><a href=\"https://www.uptodate.com/contents/renal-disease-in-sarcoidosis/abstract/2\" class=\"nounderline abstract_t\">Casella FJ, Allon M. The kidney in sarcoidosis. J Am Soc Nephrol 1993; 3:1555.</a></li><li><a href=\"https://www.uptodate.com/contents/renal-disease-in-sarcoidosis/abstract/3\" class=\"nounderline abstract_t\">BERGER KW, RELMAN AS. Renal impairment due to sarcoid infiltration of the kidney; report of a case proved by renal biopsies before and after treatment with cortisone. N Engl J Med 1955; 252:44.</a></li><li><a href=\"https://www.uptodate.com/contents/renal-disease-in-sarcoidosis/abstract/4\" class=\"nounderline abstract_t\">LOFGREN S, SNELLMAN B, LINDGREN AG. Renal complications in sarcoidosis; functional and biopsy studies. Acta Med Scand 1957; 159:295.</a></li><li><a href=\"https://www.uptodate.com/contents/renal-disease-in-sarcoidosis/abstract/5\" class=\"nounderline abstract_t\">Lebacq E, Desmet V, Verhaegen H. Renal involvement in sarcoidosis. Postgrad Med J 1970; 46:526.</a></li><li><a href=\"https://www.uptodate.com/contents/renal-disease-in-sarcoidosis/abstract/6\" class=\"nounderline abstract_t\">MacSearraigh ET, Doyle CT, Twomey M, O'Sullivan DJ. Sarcoidosis with renal involvement. Postgrad Med J 1978; 54:528.</a></li><li><a href=\"https://www.uptodate.com/contents/renal-disease-in-sarcoidosis/abstract/7\" class=\"nounderline abstract_t\">Bergner R, Hoffmann M, Waldherr R, Uppenkamp M. Frequency of kidney disease in chronic sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis 2003; 20:126.</a></li><li><a href=\"https://www.uptodate.com/contents/renal-disease-in-sarcoidosis/abstract/8\" class=\"nounderline abstract_t\">Berliner AR, Haas M, Choi MJ. Sarcoidosis: the nephrologist's perspective. Am J Kidney Dis 2006; 48:856.</a></li><li><a href=\"https://www.uptodate.com/contents/renal-disease-in-sarcoidosis/abstract/9\" class=\"nounderline abstract_t\">Singer FR, Adams JS. Abnormal calcium homeostasis in sarcoidosis. N Engl J Med 1986; 315:755.</a></li><li><a href=\"https://www.uptodate.com/contents/renal-disease-in-sarcoidosis/abstract/10\" class=\"nounderline abstract_t\">LONGCOPE WT, FREIMAN DG. A study of sarcoidosis; based on a combined investigation of 160 cases including 30 autopsies from The Johns Hopkins Hospital and Massachusetts General Hospital. Medicine (Baltimore) 1952; 31:1.</a></li><li><a href=\"https://www.uptodate.com/contents/renal-disease-in-sarcoidosis/abstract/11\" class=\"nounderline abstract_t\">Rizzato G. Sarcoidosis in Italy. Sarcoidosis 1992; 9(Suppl 1):145.</a></li><li><a href=\"https://www.uptodate.com/contents/renal-disease-in-sarcoidosis/abstract/12\" class=\"nounderline abstract_t\">Singer DR, Evans DJ. Renal impairment in sarcoidosis: granulomatous nephritis as an isolated cause (two case reports and review of the literature). Clin Nephrol 1986; 26:250.</a></li><li><a href=\"https://www.uptodate.com/contents/renal-disease-in-sarcoidosis/abstract/13\" class=\"nounderline abstract_t\">Korzets Z, Schneider M, Taragan R, et al. Acute renal failure due to sarcoid granulomatous infiltration of the renal parenchyma. Am J Kidney Dis 1985; 6:250.</a></li><li><a href=\"https://www.uptodate.com/contents/renal-disease-in-sarcoidosis/abstract/14\" class=\"nounderline abstract_t\">O'Riordan E, Willert RP, Reeve R, et al. Isolated sarcoid granulomatous interstitial nephritis: review of five cases at one center. Clin Nephrol 2001; 55:297.</a></li><li><a href=\"https://www.uptodate.com/contents/renal-disease-in-sarcoidosis/abstract/15\" class=\"nounderline abstract_t\">Joss N, Morris S, Young B, Geddes C. Granulomatous interstitial nephritis. Clin J Am Soc Nephrol 2007; 2:222.</a></li><li class=\"breakAll\">Hoffbrand BI. The kidney in sarcoidosis. In: Sarcoidosis and Other Granulomatous Disorders, James DG (Ed), Marcel Dekker, New York 1994. p.335.</li><li class=\"breakAll\">Lower E. Renal sarcoidosis. In: Sarcoidosis, Baughman R (Ed), Taylor &amp; Francis, New York 2006. p.651.</li><li class=\"breakAll\">Rizzato G. Calcium Metabolism. In: Sarcoidosis, Baughman R (Ed), Taylor &amp; Francis, New York 2006. p.635.</li><li><a href=\"https://www.uptodate.com/contents/renal-disease-in-sarcoidosis/abstract/19\" class=\"nounderline abstract_t\">Mah&eacute;vas M, Lescure FX, Boffa JJ, et al. Renal sarcoidosis: clinical, laboratory, and histologic presentation and outcome in 47 patients. Medicine (Baltimore) 2009; 88:98.</a></li><li><a href=\"https://www.uptodate.com/contents/renal-disease-in-sarcoidosis/abstract/20\" class=\"nounderline abstract_t\">L&ouml;ffler C, L&ouml;ffler U, Tuleweit A, et al. Renal sarcoidosis: epidemiological and follow-up data in a cohort of 27 patients. Sarcoidosis Vasc Diffuse Lung Dis 2015; 31:306.</a></li><li><a href=\"https://www.uptodate.com/contents/renal-disease-in-sarcoidosis/abstract/21\" class=\"nounderline abstract_t\">Dahl K, Canetta PA, D'Agati VD, Radhakrishnan J. A 56-year-old woman with sarcoidosis and acute renal failure. Kidney Int 2008; 74:817.</a></li><li><a href=\"https://www.uptodate.com/contents/renal-disease-in-sarcoidosis/abstract/22\" class=\"nounderline abstract_t\">Goldszer RC, Galvanek EG, Lazarus JM. Glomerulonephritis in a patient with sarcoidosis. Report of a case and review of the literature. Arch Pathol Lab Med 1981; 105:478.</a></li><li><a href=\"https://www.uptodate.com/contents/renal-disease-in-sarcoidosis/abstract/23\" class=\"nounderline abstract_t\">Jones B, Fowler J. Membranous nephropathy associated with sarcoidosis. Response to prednisolone. Nephron 1989; 52:101.</a></li><li><a href=\"https://www.uptodate.com/contents/renal-disease-in-sarcoidosis/abstract/24\" class=\"nounderline abstract_t\">van Uum SH, Cooreman MP, Assmann KJ, Wetzels JF. A 58-year-old man with sarcoidosis complicated by focal crescentic glomerulonephritis. Nephrol Dial Transplant 1997; 12:2703.</a></li><li><a href=\"https://www.uptodate.com/contents/renal-disease-in-sarcoidosis/abstract/25\" class=\"nounderline abstract_t\">Inui N, Murayama A, Sasaki S, et al. Correlation between 25-hydroxyvitamin D3 1 alpha-hydroxylase gene expression in alveolar macrophages and the activity of sarcoidosis. Am J Med 2001; 110:687.</a></li><li><a href=\"https://www.uptodate.com/contents/renal-disease-in-sarcoidosis/abstract/26\" class=\"nounderline abstract_t\">Rizzato G, Fraioli P, Montemurro L. Nephrolithiasis as a presenting feature of chronic sarcoidosis. Thorax 1995; 50:555.</a></li><li><a href=\"https://www.uptodate.com/contents/renal-disease-in-sarcoidosis/abstract/27\" class=\"nounderline abstract_t\">Rizzato G, Palmieri G, Agrati AM, Zanussi C. The organ-specific extrapulmonary presentation of sarcoidosis: a frequent occurrence but a challenge to an early diagnosis. A 3-year-long prospective observational study. Sarcoidosis Vasc Diffuse Lung Dis 2004; 21:119.</a></li><li><a href=\"https://www.uptodate.com/contents/renal-disease-in-sarcoidosis/abstract/28\" class=\"nounderline abstract_t\">Procino G, Mastrofrancesco L, Tamma G, et al. Calcium-sensing receptor and aquaporin 2 interplay in hypercalciuria-associated renal concentrating defect in humans. An in vivo and in vitro study. PLoS One 2012; 7:e33145.</a></li><li><a href=\"https://www.uptodate.com/contents/renal-disease-in-sarcoidosis/abstract/29\" class=\"nounderline abstract_t\">Stuart CA, Neelon FA, Lebovitz HE. Disordered control of thirst in hypothalamic-pituitary sarcoidosis. N Engl J Med 1980; 303:1078.</a></li><li><a href=\"https://www.uptodate.com/contents/renal-disease-in-sarcoidosis/abstract/30\" class=\"nounderline abstract_t\">Levi M, Peterson L, Berl T. Mechanism of concentrating defect in hypercalcemia. Role of polydipsia and prostaglandins. Kidney Int 1983; 23:489.</a></li><li><a href=\"https://www.uptodate.com/contents/renal-disease-in-sarcoidosis/abstract/31\" class=\"nounderline abstract_t\">Brause M, Magnusson K, Degenhardt S, et al. Renal involvement in sarcoidosis--a report of 6 cases. Clin Nephrol 2002; 57:142.</a></li><li><a href=\"https://www.uptodate.com/contents/renal-disease-in-sarcoidosis/abstract/32\" class=\"nounderline abstract_t\">Robson MG, Banerjee D, Hopster D, Cairns HS. Seven cases of granulomatous interstitial nephritis in the absence of extrarenal sarcoid. Nephrol Dial Transplant 2003; 18:280.</a></li><li><a href=\"https://www.uptodate.com/contents/renal-disease-in-sarcoidosis/abstract/33\" class=\"nounderline abstract_t\">Thumfart J, M&uuml;ller D, Rudolph B, et al. Isolated sarcoid granulomatous interstitial nephritis responding to infliximab therapy. Am J Kidney Dis 2005; 45:411.</a></li><li><a href=\"https://www.uptodate.com/contents/renal-disease-in-sarcoidosis/abstract/34\" class=\"nounderline abstract_t\">Chopra A, Brasher P, Chaudhry H, et al. Proteinuria in sarcoidosis: Prevalence and risk factors in a consecutive outpatient cohort. Sarcoidosis Vasc Diffuse Lung Dis 2017; 34:142.</a></li><li><a href=\"https://www.uptodate.com/contents/renal-disease-in-sarcoidosis/abstract/35\" class=\"nounderline abstract_t\">Javaud N, Belenfant X, Stirnemann J, et al. Renal granulomatoses: a retrospective study of 40 cases and review of the literature. Medicine (Baltimore) 2007; 86:170.</a></li><li><a href=\"https://www.uptodate.com/contents/renal-disease-in-sarcoidosis/abstract/36\" class=\"nounderline abstract_t\">Bijol V, Mendez GP, Nos&eacute; V, Rennke HG. Granulomatous interstitial nephritis: a clinicopathologic study of 46 cases from a single institution. Int J Surg Pathol 2006; 14:57.</a></li><li><a href=\"https://www.uptodate.com/contents/renal-disease-in-sarcoidosis/abstract/37\" class=\"nounderline abstract_t\">Adams AL, Cook WJ. Granulomatous interstitial nephritis secondary to histoplasmosis. Am J Kidney Dis 2007; 50:681.</a></li><li><a href=\"https://www.uptodate.com/contents/renal-disease-in-sarcoidosis/abstract/38\" class=\"nounderline abstract_t\">Yoo DH, Hrycaj P, Miranda P, et al. A randomised, double-blind, parallel-group study to demonstrate equivalence in efficacy and safety of CT-P13 compared with innovator infliximab when coadministered with methotrexate in patients with active rheumatoid arthritis: the PLANETRA study. Ann Rheum Dis 2013; 72:1613.</a></li><li><a href=\"https://www.uptodate.com/contents/renal-disease-in-sarcoidosis/abstract/39\" class=\"nounderline abstract_t\">Veltkamp M, Drent M, Baughman RP. Infliximab or biosimilars in sarcoidosis; to switch or not to switch? Sarcoidosis Vasc Diffuse Lung Dis 2016; 32:280.</a></li><li><a href=\"https://www.uptodate.com/contents/renal-disease-in-sarcoidosis/abstract/40\" class=\"nounderline abstract_t\">Auinger M, Irsigler K, Breiteneder S, Ulrich W. Normocalcaemic hepatorenal sarcoidosis with crescentic glomerulonephritis. Nephrol Dial Transplant 1997; 12:1474.</a></li><li><a href=\"https://www.uptodate.com/contents/renal-disease-in-sarcoidosis/abstract/41\" class=\"nounderline abstract_t\">Fraioli P, Montemurro L, Castrignano L, Rizzato G. Retroperitoneal involvement in sarcoidosis. Sarcoidosis 1990; 7:101.</a></li><li><a href=\"https://www.uptodate.com/contents/renal-disease-in-sarcoidosis/abstract/42\" class=\"nounderline abstract_t\">Godin M, Fillastre JP, Ducastelle T, et al. Sarcoidosis. Retroperitoneal fibrosis, renal arterial involvement, and unilateral focal glomerulosclerosis. Arch Intern Med 1980; 140:1240.</a></li><li><a href=\"https://www.uptodate.com/contents/renal-disease-in-sarcoidosis/abstract/43\" class=\"nounderline abstract_t\">Mariano RT, Sussman SK. Sarcoidosis of the ureter. AJR Am J Roentgenol 1998; 171:1431.</a></li><li><a href=\"https://www.uptodate.com/contents/renal-disease-in-sarcoidosis/abstract/44\" class=\"nounderline abstract_t\">Gross KR, Malleson PN, Culham G, et al. Vasculopathy with renal artery stenosis in a child with sarcoidosis. J Pediatr 1986; 108:724.</a></li><li><a href=\"https://www.uptodate.com/contents/renal-disease-in-sarcoidosis/abstract/45\" class=\"nounderline abstract_t\">Aouizerate J, Matignon M, Kamar N, et al. Renal transplantation in patients with sarcoidosis: a French multicenter study. Clin J Am Soc Nephrol 2010; 5:2101.</a></li><li><a href=\"https://www.uptodate.com/contents/renal-disease-in-sarcoidosis/abstract/46\" class=\"nounderline abstract_t\">Mann DM, Fyfe B, Osband AJ, et al. Sarcoidosis within a renal allograft: a case report and review of the literature. Transplant Proc 2013; 45:838.</a></li></ol></div><div id=\"topicVersionRevision\">Topic 7186 Version 13.0</div></div>","outline":"<div id=\"outlineSections\"><h2>Topic Outline</h2><ul id=\"innerOutline\"><li class=\"sr-button\"><a href=\"#H13\"><span>SUMMARY &amp; RECOMMENDATIONS</span></a></li><li><a href=\"#H215467823\" id=\"outline-link-H215467823\">INTRODUCTION</a></li><li><a href=\"#H2\" id=\"outline-link-H2\">EPIDEMIOLOGY</a></li><li><a href=\"#H778374900\" id=\"outline-link-H778374900\">PROGNOSIS</a></li><li><a href=\"#H778373296\" id=\"outline-link-H778373296\">NEPHROLITHIASIS AND NEPHROCALCINOSIS</a><ul><li><a href=\"#H197103143\" id=\"outline-link-H197103143\">Pathogenesis</a></li><li><a href=\"#H778373487\" id=\"outline-link-H778373487\">Clinical manifestations</a></li><li><a href=\"#H778374472\" id=\"outline-link-H778374472\">Diagnosis</a></li><li><a href=\"#H778374390\" id=\"outline-link-H778374390\">Differential diagnosis</a></li><li><a href=\"#H778375028\" id=\"outline-link-H778375028\">Treatment</a></li></ul></li><li><a href=\"#H778373310\" id=\"outline-link-H778373310\">INTERSTITIAL NEPHRITIS</a><ul><li><a href=\"#H778373331\" id=\"outline-link-H778373331\">Pathogenesis</a></li><li><a href=\"#H778373722\" id=\"outline-link-H778373722\">Clinical manifestations</a></li><li><a href=\"#H778373995\" id=\"outline-link-H778373995\">Diagnosis</a></li><li><a href=\"#H778374278\" id=\"outline-link-H778374278\">Differential diagnosis</a></li><li><a href=\"#H778374594\" id=\"outline-link-H778374594\">Treatment</a></li></ul></li><li><a href=\"#H778373317\" id=\"outline-link-H778373317\">GLOMERULONEPHRITIS</a></li><li><a href=\"#H778373324\" id=\"outline-link-H778373324\">URETERAL OBSTRUCTION AND OTHER RENAL MANIFESTATIONS</a></li><li><a href=\"#H12\" id=\"outline-link-H12\">RENAL TRANSPLANTATION</a></li><li><a href=\"#H3406089238\" id=\"outline-link-H3406089238\">SOCIETY GUIDELINE LINKS</a></li><li><a href=\"#H13\" id=\"outline-link-H13\">SUMMARY AND RECOMMENDATIONS</a></li><li><a href=\"#references\">REFERENCES</a></li></ul></div><div><h2>GRAPHICS <a href=\"#\" id=\"viewAllGraphicsLink\">View All</a></h2><div id=\"outlineGraphics\"><ul><li><div id=\"NEPH/7186|PIC\" class=\"openRelatedGraphics\"><a href=\"#\" title=\"PICTURES\">PICTURES</a></div><ul><li><a href=\"image.htm?imageKey=NEPH/67591\" class=\"graphic graphic_picture\">- Granulomatous ISN</a></li></ul></li></ul></div></div><div><h2>RELATED TOPICS</h2><div id=\"outlineTopics\"><ul><li class=\"plainItem\"><a href=\"topic.htm?path=clinical-manifestations-and-causes-of-nephrogenic-diabetes-insipidus\" class=\"medical medical_review\">Clinical manifestations and causes of nephrogenic diabetes insipidus</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=clinical-manifestations-and-diagnosis-of-acute-interstitial-nephritis\" class=\"medical medical_review\">Clinical manifestations and diagnosis of acute interstitial nephritis</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=clinical-manifestations-and-diagnosis-of-pulmonary-sarcoidosis\" class=\"medical medical_review\">Clinical manifestations and diagnosis of pulmonary sarcoidosis</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=clinical-manifestations-and-diagnosis-of-retroperitoneal-fibrosis\" class=\"medical medical_review\">Clinical manifestations and diagnosis of retroperitoneal fibrosis</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=diagnosis-and-acute-management-of-suspected-nephrolithiasis-in-adults\" class=\"medical medical_review\">Diagnosis and acute management of suspected nephrolithiasis in adults</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=diagnosis-of-polyuria-and-diabetes-insipidus\" class=\"medical medical_review\">Diagnosis of polyuria and diabetes insipidus</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=hypercalcemia-in-granulomatous-diseases\" class=\"medical medical_review\">Hypercalcemia in granulomatous diseases</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=nephrocalcinosis\" class=\"medical medical_review\">Nephrocalcinosis</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=pathology-and-pathogenesis-of-sarcoidosis\" class=\"medical medical_review\">Pathology and pathogenesis of sarcoidosis</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=society-guideline-links-chronic-kidney-disease-in-adults\" class=\"medical medical_society_guidelines\">Society guideline links: Chronic kidney disease in adults</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=treatment-of-pulmonary-sarcoidosis-disease-refractory-to-glucocorticoid-therapy\" class=\"medical medical_review\">Treatment of pulmonary sarcoidosis: Disease refractory to glucocorticoid therapy</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=treatment-of-retroperitoneal-fibrosis\" class=\"medical medical_review\">Treatment of retroperitoneal fibrosis</a></li></ul></div></div>","javascript":null}